221 related articles for article (PubMed ID: 3004993)
21. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
Westfall MV; Wahler GM; Fujino K; Solaro RJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):58-63. PubMed ID: 1346167
[TBL] [Abstract][Full Text] [Related]
23. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
Brown L; Erdmann E
Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
[TBL] [Abstract][Full Text] [Related]
24. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.
Shahid M; Rodger IW
Br J Pharmacol; 1989 Sep; 98(1):291-301. PubMed ID: 2478244
[TBL] [Abstract][Full Text] [Related]
25. Cardiotonic effect of phthalazinol (EG-626) in the isolated guinea pig by myocardium: mechanical and electrophysiological study.
Shigenobu K; Iwayama Y; Sakai R; Kasuya Y
J Pharmacobiodyn; 1980 Oct; 3(10):543-52. PubMed ID: 6110715
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of the bipyridines: amrinone and milrinone.
Alousi AA; Johnson DC
Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
[TBL] [Abstract][Full Text] [Related]
27. Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.
Siegl PK; Morgan G; Sweet CS
J Cardiovasc Pharmacol; 1984; 6(2):281-7. PubMed ID: 6200717
[TBL] [Abstract][Full Text] [Related]
28. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
[TBL] [Abstract][Full Text] [Related]
29. Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium.
Maier LS; Schwan C; Schillinger W; Minami K; Schütt U; Pieske B
Cardiovasc Res; 2000 Mar; 45(4):913-24. PubMed ID: 10728417
[TBL] [Abstract][Full Text] [Related]
30. Studies on the mechanism of positive inotropic activity of Ro 13-6438, a structurally novel cardiotonic agent with vasodilating properties.
Holck M; Thorens S; Muggli R; Eigenmann R
J Cardiovasc Pharmacol; 1984; 6(3):520-30. PubMed ID: 6202981
[TBL] [Abstract][Full Text] [Related]
31. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
Hayes JS; Wyss VL; Wilson HC; Robertson DW; Kauffman RF
J Pharmacol Exp Ther; 1986 Nov; 239(2):375-81. PubMed ID: 3021955
[TBL] [Abstract][Full Text] [Related]
33. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
Endoh M; Yamashita S; Taira N
J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
Alousi AA; Stankus GP; Stuart JC; Walton LH
J Cardiovasc Pharmacol; 1983; 5(5):804-11. PubMed ID: 6195468
[TBL] [Abstract][Full Text] [Related]
36. Amrinone activates K+-depolarized atrial and ventricular myocardium of guinea pigs.
Adams HR; Rhody J; Sutko JL
Circ Res; 1982 Nov; 51(5):662-5. PubMed ID: 7139883
[TBL] [Abstract][Full Text] [Related]
37. Increase in calcium sensitivity of cardiac myofibrils contributes to the cardiotonic action of sulmazole.
van Meel JC; Zimmermann R; Diederen W; Erdman E; Mrwa U
Biochem Pharmacol; 1988 Jan; 37(2):213-20. PubMed ID: 2829914
[TBL] [Abstract][Full Text] [Related]
38. New inotropic concepts: rationale for and differences between calcium sensitizers and phosphodiesterase inhibitors.
Holubarsch C
Cardiology; 1997; 88 Suppl 2():12-20. PubMed ID: 9142431
[TBL] [Abstract][Full Text] [Related]
39. Studies on the mechanism of the cardiotonic activity of MDL 19205: effects on several biochemical systems.
Kariya T; Wille LJ; Dage RC
J Cardiovasc Pharmacol; 1984; 6(1):50-5. PubMed ID: 6199611
[TBL] [Abstract][Full Text] [Related]
40. Mechanism underlying the strong positive inotropic effects of LND-623: specific inhibition of Na, K-ATPase isoforms and exclusion of cellular sites of contractile control.
Maixent JM; Lelièvre L; Berrebi-Bertrand I
Cardiovasc Drugs Ther; 1998 Dec; 12(6):585-94. PubMed ID: 10410828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
